Skip to main content
GRCGorman-Rupp Company (The)Sell5.1·$90.44
GRC · Decision

Should you buy Gorman-Rupp Company (The) (GRC)?

Updated

A financially sound specialty industrial machinery company with strong momentum—RSI at 76, rising on-balance volume, and a near-perfect financial health score—has moved above its analyst consensus target with effectively no positive headroom remaining, while earnings estimates are drifting lower and a 28.9x forward earnings multiple prices in a growth trajectory the current estimate revisions do not support.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
SELL
Score
5.1/10
Price
$90.44
Entry / Take Profit (TP) / Stop Loss (SL)
/ $89.55 / $84.66

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

The stock is trading above the 200-day moving average with rising on-balance volume and a bullish MACD configuration, indicating broad participation in the advance and a constructive underlying trend that has driven price to within 1.4% of its 52-week high.

Stable
Momentum breakdown
Expectation
Price holds above the 200-day moving average and on-balance volume continues rising for 3 additional months, confirming the uptrend remains intact.

CounterRSI at 76 is in overbought territory, and the stock has already exceeded its analyst consensus target—both conditions historically associated with near-term mean reversion rather than continued momentum, particularly when earnings estimates are moving lower.

At a forward price-to-earnings multiple of 28.9x and a PEG ratio of 2.53, the stock is priced well above average for an industrial machinery business, at the same time that earnings estimates are drifting lower—creating a double-risk of both multiple compression and earnings revision headwinds.

Stable
Value
Expectation
Forward earnings multiple compresses below 22x as either price pulls back or estimates are revised upward, restoring a more defensible valuation anchor.

CounterA premium multiple can persist when a company is consistently beating and raising; the three most recent quarterly earnings beats (including two large beats above 27% and 38% surprise) suggest analysts may be anchoring estimates too conservatively, which could result in upward revisions rather than further deterioration.

The company has achieved a Piotroski financial health score of 9 out of 9—indicating strong balance sheet, profitability, and operating efficiency metrics across all evaluated dimensions—combined with above-average free cash flow quality, providing a durable foundation for the business regardless of near-term price action.

Stable
Quality
Expectation
Financial health metrics are maintained at or above current levels over the next 4 reported quarters, with no deterioration in profitability or cash conversion ratios.

CounterThe Piotroski score is a backward-looking snapshot; current ratio and liquidity components at the maximum do not protect against a cyclical revenue decline, and the below-average gross margin suggests the cost structure may be sensitive to volume or input price headwinds.

▸ Show 2 more pillars

The stock has moved above its near-term take-profit target at $84.85, with the current price of $85.40 leaving approximately -0.6% of headroom—meaning the stock has already priced in the near-term upside and the risk/reward of approximately -0.11-to-1 is unfavorable for new buyers.

Stable
Price targets
Expectation
Price falls back below $78, restoring at least 8% of potential upside to the prior resistance level and resetting the reward/risk geometry to favorable.

CounterA stock that breaks and holds above its technical target can establish a new, higher equilibrium; if the next earnings print beats meaningfully, analysts may revise consensus upward and create fresh upside potential without the stock needing to pull back.

Forward earnings estimates are trending downward—a signal that the analyst community expects business conditions to moderate—which, combined with a premium valuation multiple, means the stock is becoming progressively more expensive on a forward basis even as estimates erode.

Stable
Bear case
Expectation
Earnings estimate revisions turn positive (upward) over the next 2 months, with at least 2 analyst upgrades or estimate increases restoring positive estimate momentum.

CounterEstimate drift can reverse sharply after a strong earnings print; the company's three most recent quarterly beats include a 38.8% surprise in the most recent quarter, suggesting management guidance may be running conservatively and the next print could trigger upward revisions.

→ Full pillar scorecard with all 5 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1The stock is trading above the 200-day moving average with rising on-balance volume and a bullish MACD configuration, indicating broad participation in the advance and a constructive underlying trend that has driven price to within 1.4% of its 52-week high.

    Trip ifRSI falls below 50 and price crosses below the 200-day moving average for 2 consecutive weeks, invalidating the positive momentum thesis.

  • P2At a forward price-to-earnings multiple of 28.9x and a PEG ratio of 2.53, the stock is priced well above average for an industrial machinery business, at the same time that earnings estimates are drifting lower—creating a double-risk of both multiple compression and earnings revision headwinds.

    Trip ifForward P/E multiple compresses below 22x, removing the expensive-valuation concern by bringing the stock back to a more defensible multiple.

  • P3The company has achieved a Piotroski financial health score of 9 out of 9—indicating strong balance sheet, profitability, and operating efficiency metrics across all evaluated dimensions—combined with above-average free cash flow quality, providing a durable foundation for the business regardless of near-term price action.

    Trip ifPiotroski F-score falls below 6 for 2 consecutive reported quarters, indicating meaningful deterioration in financial health quality.

  • P4The stock has moved above its near-term take-profit target at $84.85, with the current price of $85.40 leaving approximately -0.6% of headroom—meaning the stock has already priced in the near-term upside and the risk/reward of approximately -0.11-to-1 is unfavorable for new buyers.

    Trip ifAnalyst consensus price target revises upward above $100, restoring at least 17% potential upside from the current price and creating favorable reward/risk for new entry.

  • P5Forward earnings estimates are trending downward—a signal that the analyst community expects business conditions to moderate—which, combined with a premium valuation multiple, means the stock is becoming progressively more expensive on a forward basis even as estimates erode.

    Trip ifAnalyst EPS estimate revisions for the next reported quarter turn positive for at least 3 consecutive weeks, ending the downward drift in forward estimates.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for Gorman-Rupp Company (The) (GRC) is SELL_IF_HOLDING with medium conviction, score 5.1/10 at $90.44. The F-path SELL output reflects an overall score of 5.1 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of -2.03 is supplementary context, not the trigger.

2. Entry, target, and stop

The engine's exit framework anchors to a tactical sell band near $90.44, with structural invalidation at $84.66. The asymmetric R:R against a reversal hypothesis is -0.16 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

3. What the engine sees

On the bull side: Strong earnings beat streak (3/4); Strong growth profile. On the bear side: Analyst target reached - limited upside remaining; Near 52-week high (-0.9% away); Earnings estimates trending DOWN. Active engine warnings: V8: Target reached (-30.5% upside), V9 Gate Failed: ASYMMETRY:-2.0=NEGATIVE.

4. What would change the verdict

The dominant failed gate is reward-to-risk (NEGATIVE). SELL flips back toward HOLD if reward-to-risk recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is MOMENTUM:4.8>=4.5.

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates GRC — 10-dimension breakdown →

Bull case

  • Strong earnings beat streak (3/4)
  • Strong growth profile

Bear case

  • Analyst target reached - limited upside remaining
  • Near 52-week high (-0.9% away)
  • Earnings estimates trending DOWN
Home Stocks GRC Buy or sell?